secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caribou Biosciences, Inc. (CRBU)
CIK:        0001619856
Form:       8-K/A
Filed at:   2024-09-27T23:59:59+00:00
Accession:  0001619856-24-000074
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Caribou Biosciences appoints Ryan Fischesser interim CFO and grants 25,000 RSUs
-------------------------------------------------------------------------------

- Ryan Fischesser designated interim principal financial officer and accounting officer effective Sept 27, 2024, following Jason O'Byrne's resignation.
- Fischesser to receive 25,000 RSUs on Nov 20, 2024, vesting fully on Nov 20, 2025, subject to continued employment.
- The original 8-K filed Sept 3, 2024 reported O'Byrne's resignation; this amendment supplements compensatory terms.
- Fischesser previously served as VP of Finance and Controller.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1619856/000161985624000074/0001619856-24-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1619856/000161985624000074/crbu-20240901.htm
  HTML page:      https://secwatch.observer/filing/0001619856-24-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer